Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

NCT02315131 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

53

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Chronic Obstructive Pulmonary Disease (COPD

Interventions

DRUG: TV46017
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.